Pancreatic neuroendocrine neoplasms are rare cancers with broad challenges for their management
Sandra Tamargo Díaz, business development manager at BQC, has participated in the following article about "Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms" Abstract Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for their management. The main clinical obstacles are the high rate of patients
